Hengan International Group Company Ltd
HKEX:1044
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.65
29.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hengan International Group Company Ltd
Hengan International Group Company Ltd
Accounts Receivables
Hengan International Group Company Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Accounts Receivables
¥2.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
|
S
|
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
|
Accounts Receivables
¥310.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Accounts Receivables
¥383.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Accounts Receivables
¥561.8m
|
CAGR 3-Years
44%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Accounts Receivables
¥249.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Accounts Receivables
¥102m
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hengan International Group Company Ltd
Glance View
In the bustling city of Jinjiang, the entrepreneurial spirit took root in 1985 with the founding of Hengan International Group Company Ltd. Originally a humble manufacturer of sanitary napkins, the company embarked on a relentless journey of innovation and strategic expansion. Hengan's founders, understanding the burgeoning demand for personal hygiene products in a rapidly modernizing China, strategically focused on building a brand renowned for quality and reliability. They cultivated a robust distribution network across the country, ensuring that their products were accessible to the burgeoning middle class. Over the years, Hengan expanded its product portfolio to include a diverse range of tissue papers, disposable diapers, and even reproductive health products, positioning itself as a trusted household name across many segments. Hengan's success lies in its keen ability to navigate shifting consumer preferences and maintain efficient, large-scale production capabilities. The company capitalizes on extensive market research to continually refine its product offerings and price them competitively, catering to a diverse customer base. By leveraging economies of scale and investing in advanced manufacturing technologies, Hengan effectively manages production costs while maintaining high quality. Its revenues are bolstered by a well-integrated supply chain and a marketing strategy that resonates with customer values, allowing it to penetrate rural and urban markets alike. Through a balanced strategy of organic growth and strategic acquisitions, Hengan International has cemented its position as one of the leading personal hygiene product manufacturers in Asia.
See Also
What is Hengan International Group Company Ltd's Accounts Receivables?
Accounts Receivables
2.6B
CNY
Based on the financial report for Jun 30, 2024, Hengan International Group Company Ltd's Accounts Receivables amounts to 2.6B CNY.
What is Hengan International Group Company Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
4%
Over the last year, the Accounts Receivables growth was -9%. The average annual Accounts Receivables growth rates for Hengan International Group Company Ltd have been -6% over the past three years , -4% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
